Anti-obesity drugs fatten Novo Nordisk profits ...Middle East

Daily Sun - News
Anti-obesity drugs fatten Novo Nordisk profits
COPENHAGEN: Danish drugmaker Novo Nordisk reported Thursday a sharp rise in third quarter sales and profits driven by the success of its anti-diabetes and anti-obesity treatments Ozempic and Wegovy.Net profit rose to 22.5 billion kroner ($3.2 billion) in the period from July to September, a 56 percent increase from the same time last year.Sales meanwhile rose 29 percent to 58.7 billion kroner.The results came in slightly better than analyst forecasts of a net profit of around 21.5 billion kroner on sales of 57.7 billion.Over the first nine months of the year, sales rose by 33 percent to 166.4 billion kroner at constant exchange rates, with a 58 percent jump in sales for Ozempic and a near fi

Hence then, the article about anti obesity drugs fatten novo nordisk profits was published today ( ) and is available on Daily Sun ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Anti-obesity drugs fatten Novo Nordisk profits )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News